Vascular Solutions (VASC) 11.27 0.41

Vascular Solutions, Inc.
(VASC) 11.27 0.41

Last Trade:	11.26	Day Range:	10.97 - 11.29
Trade Time:	12:02PM	52wk Range:	9.90 - 13.75
Prev. Close:	10.85	Market Cap:	187.18M
Open:	10.97	Div Yield:	0
Volume:	7024	PE:
EPS:	0.57

The Latest On VASC

Hearing Vascular Solutions Downgraded to Neutral at Dougherty 10/26/11 12:32pm

Duncan Williams Raises PT On Vascular Solutions To $17 8/3/11 8:03am

Duncan-Williams Previews 2Q Earnings for Vascular Solutions 7/29/11 9:25am

Wedbush Comments On "Solid" VASC Quarter 4/20/11 7:00am

Vascular Solutions Guides Q2 EPS $0.11-$0.13; Revenue $22.3M-$22.7M (VASC) 4/19/11 3:11pm

Vascular Solutions Reports Q1 EPS of $.10 vs. $.10 4/19/11 3:10pm

Vascular Solutions (NASDAQ: VASC) Reports EPS of $0.10 vs. $0.10 Estimate; Revenue $21.30 vs. $21.14 4/19/11 3:10pm

Vascular Solutions Reports Q4 EPS of $.12 vs. $.12 2/1/11 4:10pm

Vascular Solutions and Shepherd Scientific Announce U.S. Distribution of New Products 9/20/10 8:21am

Healthcare Conference Update (JNJ, BSX, ATEC, BAX, ZOLL) 2/22/10 5:22pm

Stocks To Watch (BAC, ININ, PIR, DARA, VASC) 10/13/09 3:50am

Hearing Vascular Solutions Downgraded to Neutral at Dougherty 10/26/11

Duncan Williams Raises PT On Vascular Solutions To $17 8/3/11

Duncan-Williams Previews 2Q Earnings for Vascular Solutions 7/29/11

Wedbush Comments On "Solid" VASC Quarter 4/20/11

Vascular Solutions Guides Q2 EPS $0.11-$0.13; Revenue $22.3M-$22.7M (VASC) 4/19/11

Vascular Solutions Reports Q1 EPS of $.10 vs. $.10 4/19/11

Vascular Solutions (NASDAQ: VASC) Reports EPS of $0.10 vs. $0.10 Estimate; Revenue $21.30 vs. $21.14 4/19/11

Vascular Solutions Reports Q4 EPS of $.12 vs. $.12 2/1/11

Vascular Solutions and Shepherd Scientific Announce U.S. Distribution of New Products 9/20/10

Healthcare Conference Update (JNJ, BSX, ATEC, BAX, ZOLL) 2/22/10

Stocks To Watch (BAC, ININ, PIR, DARA, VASC) 10/13/09

Hearing Vascular Solutions Downgraded to Neutral at Dougherty 10/26/11

Duncan Williams Raises PT On Vascular Solutions To $17 8/3/11

Duncan-Williams Previews 2Q Earnings for Vascular Solutions 7/29/11

Wedbush Comments On "Solid" VASC Quarter 4/20/11

Healthcare Conference Update (JNJ, BSX, ATEC, BAX, ZOLL) 2/22/10

Trade VASC
NOW!

Partner Headlines

Select Small Caps Still Make Sense 6/13/11

10 Health Care Stocks With 100% Buy Ratings 1/28/11

Vascular Solutions Inc. Reports Operating Results (10-Q)

Press Releases

Vascular Solutions Reports Fourth Quarter Results 2/1/12 GlobeNewswire Story

Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters 2/1/12 GlobeNewswire Story

Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call on Wednesday, February 1st at 3:30 p.m. CST 1/18/12 Business Wire Story

Transradial Artery Access on the Rise and Affecting the Global Market for Vascular Closure Devices through 2015, According to Life Science Intelligence 12/7/11 Business Wire Story

Vascular Solutions to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference 11/29/11 GlobeNewswire Story

Vascular Solutions to Present at the 23rd Annual Piper Jaffray Health Care Conference 11/22/11 GlobeNewswire Story

Vascular Solutions Reports Record Third Quarter Results 8/30/11 GlobeNewswire Story

Vascular Solutions to Present at the Wedbush 2011 Life Sciences Management Access Conference 8/30/11 GlobeNewswire Story

Vascular Solutions, Inc. to Webcast Third Quarter Conference Call on Tuesday, October 25th at 3:30 p.m. CT 8/30/11 Business Wire Story

Vascular Solutions to Present at the 2011 Stifel Nicolaus Healthcare Conference 8/30/11 GlobeNewswire Story

Vascular Solutions Reports Record Second Quarter Results 8/30/11 GlobeNewswire Story

Get the latest VASC stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Vascular Solutions, Inc. stock price.

Vascular Solutions, Inc. by YCharts